Valerio Therapeutics (C4X) Financial Statements
Valerio Therapeutics Financial Overview
Valerio Therapeutics's market cap is currently $269.62M. The company's EPS TTM is $-0.05; its P/E ratio is -10.08; Valerio Therapeutics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Jun 25 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.57M | $ 1.79M | $ 1.80M | $ 1.44M | $ 4.06M |
| Gross Profit | $ 1.73M | $ 1.28M | $ 1.27M | $ 929.00K | $ 3.69M |
| Operating Income | $ -550.00K | $ -16.49M | $ -20.29M | $ -17.11M | $ -7.33M |
| EBITDA | $ 542.00K | $ -12.06M | $ -19.68M | $ -17.08M | $ -5.86M |
| Net Income | $ -4.90M | $ -23.93M | $ -20.34M | $ -19.56M | $ -5.94M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.05M | $ 1.18M | $ 6.82M | $ 14.59M | $ 17.89M |
| Total Assets | $ 15.23M | $ 17.93M | $ 35.27M | $ 43.09M | $ 53.06M |
| Total Debt | $ 7.61M | $ 13.44M | $ 9.00M | $ 10.09M | $ 9.94M |
| Net Debt | $ 6.55M | $ 12.26M | $ 2.18M | $ -4.50M | $ -3.12M |
| Total Liabilities | $ 13.16M | $ 26.19M | $ 20.47M | $ 20.82M | $ 20.12M |
| Stockholders' Equity | $ 2.08M | $ -8.93M | $ 14.80M | $ 22.27M | $ 32.94M |
| Cash Flow | |||||
| Free Cash Flow | $ 521.00K | $ -12.78M | $ -18.78M | $ -9.93M | $ -8.71M |
| Operating Cash Flow | $ 1.84M | $ -12.46M | $ -18.60M | $ -9.44M | $ -8.57M |
| Investing Cash Flow | $ -1.16M | $ -1.39M | $ -177.00K | $ -409.00K | $ -66.00K |
| Financing Cash Flow | $ -774.00K | $ 4.21M | $ 10.76M | $ 6.46M | $ 11.98M |
Currency in EUR
